A growing number of people in the US are using a new injectable body contouring product called alloClae, which uses fat harvested from donated dead bodies, or cadavers. The product is marketed as an alternative to autologous fat grafting, where a patient’s own fat is removed via liposuction and transferred into another area.

How it Works

AlloClae is quick to administer, often taking less than an hour to inject, and doesn’t require general anesthesia or a hospital setting. The aftercare instructions are also relatively easy. The product has been used by over 2,000 patients since May 2025, with many using it to add fat back into their bodies after losing weight with medications such as Ozempic and Wegovy.

Dr. Luis Macias, a double-board-certified plastic surgeon in Los Angeles, has witnessed the product’s rising popularity firsthand. He has to buy a lot of syringes at a time and talks to the representative constantly about it. The price for one 12.5cc syringe of the soft tissue corrector can run up to roughly $2,250.

Regulation and Ethics

Whole body donation and non-transplant human tissue banks are not regulated by the US Food and Drug Administration, and there is no mandatory federal accreditation or licensing requirement for these organizations. This has raised concerns about the ethics of using donated cadaver fat for profit, with some arguing that it betrays the altruism of the donors.

Caroline Van Hove, president of Tiger Aesthetics, the company that manufactures alloClae, says that the company only has contracts with tissue banks connected with the Association for Advancing Tissue and Biologics, a voluntary accrediting body. Donors have to complete a very extensive dossier releasing their consents, and it can take between 3 and 6 months to clear a donor’s medical record and approve the anatomical gift.

Original reporting: El Paso News (HLL/CB) — read the source article.